⌘K

06:05:00·1274d

SECFilingvia Quantisnow

Oncocyte Corporation filed SEC Form 8-K: Entry into a Material Definitive Agreement, Costs Associated with Exit or Disposal Activities, Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits

ByQuantisnow·Wall Street's wire, on your screen.

OCX· Oncocyte Corporation

Health Care

Original source

Oncocyte Corporation filed SEC Form 8-K: Entry into a Material Definitive Agreement, Costs Associated with Exit or Disposal Activities, Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits | Quantisnow